Third, most water-based serums lack penetration enhancers that address these barriers
May provide targeted repair and inflammation support
GLP-1s and SGLT2s: The New Power Players in Diabetes Care By 2024, more Medicare patients with T2D are sticking with GLP-1 or SGLT2 therapies as their sole treatment, doubling since 2020
Although overall utilization remains below 1 percent of eligible adolescents, a marked increase in adoption was observed in 2023
*Eligible patients without diabetes but with a BMI of 30, or 27 with comorbidities, lost an average of 21% of their body weight (-48 lbs) in a 72-week clinical trial evaluating 15 mg of tirzepatide, when combined with a reduced-calorie diet and increased physical activity
Medical applications Anti-inflammation and tissue protection: can reduce cell damage caused by hypoxia, allergies, or inflammatory reactions, and promote tissue repair